Literature DB >> 7901414

Erythema nodosum and Takayasu's arteritis after immunization with plasma derived hepatitis B vaccine.

C J Castresana-Isla1, G Herrera-Martinez, J Vega-Molina.   

Abstract

We describe a patient who developed erythema nodosum, hepatic granulomas and clinical and arteriographic manifestations of Takayasu's arteritis after inoculation with plasma-derived hepatitis B vaccine. We discuss the possibility that hepatitis B surface antigen triggered a vasculitic process in this patient.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7901414

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


  5 in total

1.  Clinical Characteristics of Patients with Erythema Nodosum and Risk of Relapse - a 17-Year Study.

Authors:  Petros Ioannou; Angeliki M Andrianaki; Dimitra Dimopoulou; Sabine Kruger-Krasagakis; Dimitra Koumaki; Diamantis P Kofteridis; George Samonis; Konstantinos Krasagakis
Journal:  Maedica (Bucur)       Date:  2022-06

Review 2.  Safety of routine childhood vaccinations. An epidemiological review.

Authors:  R T Chen; G Mootrey; F DeStefano
Journal:  Paediatr Drugs       Date:  2000 Jul-Aug       Impact factor: 3.930

3.  Kawasaki disease in an infant following immunisation with hepatitis B vaccine.

Authors:  Dan Miron; Daniel Fink; Philip J Hashkes
Journal:  Clin Rheumatol       Date:  2003-10-07       Impact factor: 3.650

4.  Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.

Authors:  Yimin Wu; Ruth D Ellis; Donna Shaffer; Erica Fontes; Elissa M Malkin; Siddhartha Mahanty; Michael P Fay; David Narum; Kelly Rausch; Aaron P Miles; Joan Aebig; Andrew Orcutt; Olga Muratova; Guanhong Song; Lynn Lambert; Daming Zhu; Kazutoyo Miura; Carole Long; Allan Saul; Louis H Miller; Anna P Durbin
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240

Review 5.  Takayasu Arteritis.

Authors:  Ricardo A G Russo; María M Katsicas
Journal:  Front Pediatr       Date:  2018-09-24       Impact factor: 3.418
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.